Assessing the Efficacy of IV Ibuprofen for Treatment of Pain in Orthopedic Trauma Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02152163|
Recruitment Status : Completed
First Posted : June 2, 2014
Last Update Posted : February 7, 2018
- To evaluate the effectiveness of around the clock (OTC) IV ibuprofen (8 doses) in decreasing pain in orthopedic trauma patients with fractures of the extremities, face, pelvis and/or ribs compared to patients not receiving the medication.
- To evaluate the effectiveness of around the clock (OTC) IV ibuprofen (8 doses) in decreasing the use of opioid analgesics among orthopedic trauma patients with fractures of the extremities, face, pelvis, and/or ribs compared to compared to patients not receiving the medication.
|Condition or disease||Intervention/treatment||Phase|
|Pain||Drug: IV Ibuprofen Drug: placebo||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||99 participants|
|Intervention Model:||Parallel Assignment|
|Primary Purpose:||Health Services Research|
|Official Title:||Assessing the Efficacy of IV Ibuprofen for Treatment of Pain in Orthopedic Trauma Patients|
|Actual Study Start Date :||October 2012|
|Actual Primary Completion Date :||April 2017|
|Actual Study Completion Date :||February 2018|
Active Comparator: IV Ibuprofen 800 mg
IV Ibuprofen 800 mg
Drug: IV Ibuprofen
Other Name: IV Caldolor
Placebo Comparator: IV Saline
- Efficacy of IV Ibuprofen in orthropedic trauma patients [ Time Frame: Pain Scale End of Day 5 ]Pain will be measured using either a Visual Anolog Scale or a Numeric Rating Scales. A baseline pain score will be obtained prior to adminstration either placebo or IV ibuprofen. Pain assessements will be obtained from both groups 4hrs/2days and then twice daily for a total of 5days.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02152163
|United States, Florida|
|Delray Medical Center|
|Delray Beach, Florida, United States, 33484|
|Principal Investigator:||Russell Weisz, MD||Delray Medical Center|